Hyperfine (NASDAQ:HYPR) Issues Quarterly Earnings Results

Hyperfine (NASDAQ:HYPR - Get Free Report) posted its earnings results on Monday. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.02, Zacks reports. Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%. The firm had revenue of $2.32 million during the quarter, compared to analyst estimates of $2.30 million. During the same quarter in the prior year, the business posted ($0.15) EPS. Hyperfine updated its FY 2025 guidance to EPS.

Hyperfine Stock Down 1.9 %

HYPR traded down $0.02 during trading on Friday, hitting $0.85. 294,797 shares of the company traded hands, compared to its average volume of 352,752. The firm has a market cap of $61.71 million, a P/E ratio of -1.47 and a beta of 0.94. The stock's fifty day moving average is $1.07 and its 200 day moving average is $1.01. Hyperfine has a one year low of $0.76 and a one year high of $1.90.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. B. Riley reduced their target price on shares of Hyperfine from $1.50 to $1.20 and set a "buy" rating for the company in a research note on Thursday. Wells Fargo & Company increased their price target on shares of Hyperfine from $1.10 to $1.29 and gave the company an "equal weight" rating in a research report on Tuesday.

About Hyperfine

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.